Literature DB >> 3303617

Tantalus revisited--the search for the ideal anti-thrombotic dose of aspirin.

D Deykin, J A Jakubowski, M J Stampfer, D Faigel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3303617      PMCID： PMC2279713     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  14 in total

1.  Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.

Authors:  J A Jakubowski; M J Stampfer; R Vaillancourt; D Faigel; D Deykin
Journal:  J Lab Clin Med       Date:  1986-12

2.  The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man.

Authors:  N Svedmyr; L Harthon; L Lundholm
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

3.  Cumulative antiplatelet effect of low-dose enteric coated aspirin.

Authors:  J A Jakubowski; M J Stampfer; R Vaillancourt; D Deykin
Journal:  Br J Haematol       Date:  1985-08       Impact factor: 6.998

4.  The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.

Authors:  M J Stampfer; J E Buring; W Willett; B Rosner; K Eberlein; C H Hennekens
Journal:  Stat Med       Date:  1985 Apr-Jun       Impact factor: 2.373

Review 5.  Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets.

Authors:  D F Bowen-Pope; R Ross; R A Seifert
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

6.  Controlled trial of aspirin in cerebral ischemia.

Authors:  W S Fields; N A Lemak; R F Frankowski; R J Hardy
Journal:  Stroke       Date:  1977 May-Jun       Impact factor: 7.914

7.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

8.  Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin.

Authors:  E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

9.  Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.

Authors:  G A FitzGerald; J A Oates; J Hawiger; R L Maas; L J Roberts; J A Lawson; A R Brash
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

10.  Identification of membrane proteins mediating the interaction of human platelets.

Authors:  D R Phillips; L K Jennings; H H Edwards
Journal:  J Cell Biol       Date:  1980-07       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.